2,767 results on '"D'ANNA, BARBARA"'
Search Results
52. Ausblick und Limitationen der Studie
- Author
-
Orschulik, Anna Barbara, Kaiser, Gabriele, Series Editor, and Orschulik, Anna Barbara
- Published
- 2021
- Full Text
- View/download PDF
53. Zusammenfassung und Diskussion der Ergebnisse
- Author
-
Orschulik, Anna Barbara, Kaiser, Gabriele, Series Editor, and Orschulik, Anna Barbara
- Published
- 2021
- Full Text
- View/download PDF
54. Implikationen für die Lehrerbildung
- Author
-
Orschulik, Anna Barbara, Kaiser, Gabriele, Series Editor, and Orschulik, Anna Barbara
- Published
- 2021
- Full Text
- View/download PDF
55. Aufbau und Konzeption der universitären Lehrveranstaltung
- Author
-
Orschulik, Anna Barbara, Kaiser, Gabriele, Series Editor, and Orschulik, Anna Barbara
- Published
- 2021
- Full Text
- View/download PDF
56. Ergebnisse zu den Einflussfaktoren bezüglich der Veränderung der Professionellen Unterrichtswahrnehmung
- Author
-
Orschulik, Anna Barbara, Kaiser, Gabriele, Series Editor, and Orschulik, Anna Barbara
- Published
- 2021
- Full Text
- View/download PDF
57. Ergebnisse zur Veränderung der Professionellen Unterrichtswahrnehmung
- Author
-
Orschulik, Anna Barbara, Kaiser, Gabriele, Series Editor, and Orschulik, Anna Barbara
- Published
- 2021
- Full Text
- View/download PDF
58. Methodischer Ansatz der Studie
- Author
-
Orschulik, Anna Barbara, Kaiser, Gabriele, Series Editor, and Orschulik, Anna Barbara
- Published
- 2021
- Full Text
- View/download PDF
59. Die Praxisphase in der Lehrerbildung
- Author
-
Orschulik, Anna Barbara, Kaiser, Gabriele, Series Editor, and Orschulik, Anna Barbara
- Published
- 2021
- Full Text
- View/download PDF
60. Professionelle Kompetenz von Lehrkräften
- Author
-
Orschulik, Anna Barbara, Kaiser, Gabriele, Series Editor, and Orschulik, Anna Barbara
- Published
- 2021
- Full Text
- View/download PDF
61. Video-Based Education with Storytelling Reduces Parents’ Fear of Topical Corticosteroid Use in Children with Atopic Dermatitis: A Randomized Controlled Trial (The EduDerm Study Part II)
- Author
-
Brunner, Corinne, Schlüer, Anna-Barbara, Znoj, Hansjoerg, Schwieger-Briel, Agnes, Luchsinger, Isabelle, Weibel, Lisa, and Theiler, Martin
- Published
- 2023
- Full Text
- View/download PDF
62. Comparison of clinical characteristics and healthcare resource use of pediatric chronic and non-chronic critically ill patients in intensive care units: a retrospective national registry study
- Author
-
Chantal Grandjean, Marie-Hélène Perez, Anne-Sylvie Ramelet, The OCToPuS Consortium, Anne-Laure Lauria, Angelo Polito, Nathalie Bochaton, Daniel Trachsel, Mark Marston, Silvia Schnidrig, Tilman Humpl, Bjarte Rogdo, Ellen Wild, Thomas Neuhaus, Sandra Stalder, Barbara Brotschi, Franziska von Arx, Anna-Barbara Schlüer, Thomas Riedel, and Pascale Van Kleef
- Subjects
health resources ,chronic disease ,chronic critical illness (CCI) ,critical care ,intensive care units ,pediatrics ,Pediatrics ,RJ1-570 - Abstract
IntroductionChronic critically ill patients (CCI) in pediatric intensive care unit (PICU) are at risk of negative health outcomes, and account for a considerable amount of ICU resources. This study aimed to (a) describe the prevalence of CCI children, (b) compare their clinical characteristics and ICU resources use with non-CCI children, and (c) identify associated risk factors of CCI.MethodsA retrospective national registry study including 2015–2017 data from the eight Swiss PICUs of five tertiary and three regional hospitals, admitting a broad case-mix of medical and surgical patients, including pre- and full-term infants. CCI patients were identified using an adapted definition: PICU length of stay (LOS) ≥8 days and dependence on ≥1 PICU technology.ResultsOut of the 12,375 PICU admissions, 982 (8%) were CCI children and compared to non-CCI children, they were younger (2.8 vs. 6.7 months), had more cardiac conditions (24% vs. 12%), and higher mortality rate (7% vs. 2%) (p
- Published
- 2023
- Full Text
- View/download PDF
63. Ganho de peso excessivo em gestantes da Atenção Primária à Saúde
- Author
-
Gonçalves, Anna Barbara Albuquerque, primary, Oliva, Guilherme Almeida Clementino, additional, Viana, Gustavo Santos, additional, Miranda, Maria Fernanda Prates de Matos, additional, Torres, Matheus Filipe, additional, Carvalho, Miguel Henrique Alves, additional, Brito, Maria Fernanda Santos Figueiredo, additional, Lopes, Wanessa Casteluber, additional, and Pinho, Lucineia de, additional
- Published
- 2024
- Full Text
- View/download PDF
64. Investigating processes influencing simulation of local Arctic wintertime anthropogenic pollution in Fairbanks, Alaska during ALPACA-2022
- Author
-
Brett, Natalie, primary, Law, Kathy S., additional, Arnold, Steve R., additional, Fochesatto, Javier G., additional, Raut, Jean-Christophe, additional, Onishi, Tatsuo, additional, Gilliam, Robert, additional, Fahey, Kathleen, additional, Huff, Deanna, additional, Pouliot, George, additional, Barret, Brice, additional, Dieudonne, Elsa, additional, Pohorsky, Roman, additional, Schmale, Julia, additional, Baccarini, Andrea, additional, Bekki, Slimane, additional, Pappaccogli, Gianluca, additional, Scoto, Federico, additional, Decesari, Stefano, additional, Donateo, Antonio, additional, Cesler-Maloney, Meeta, additional, Simpson, William, additional, Medina, Patrice, additional, D'Anna, Barbara, additional, Temime-Roussel, Brice, additional, Savarino, Joel, additional, Albertin, Sarah, additional, Mao, Jingqiu, additional, Alexander, Becky, additional, Moon, Allison, additional, DeCarlo, Peter F., additional, Selimovic, Vanessa, additional, Yokelson, Robert, additional, and Robinson, Ellis S., additional
- Published
- 2024
- Full Text
- View/download PDF
65. Hydroxymethanesulfonate and Sulfur(IV) in Fairbanks Winter During the ALPACA Study
- Author
-
Dingilian, Kayane, primary, Hebert, Elliana, additional, Battaglia, Michael, additional, Campbell, James R., additional, Cesler-Maloney, Meeta, additional, Simpson, William, additional, St. Clair, Jason M., additional, Dibb, Jack, additional, Temime-Roussel, Brice, additional, D’Anna, Barbara, additional, Moon, Allison, additional, Alexander, Becky, additional, Yang, Yuhan, additional, Nenes, Athanasios, additional, Mao, Jingqiu, additional, and Weber, Rodney J., additional
- Published
- 2024
- Full Text
- View/download PDF
66. Constraining stellar tidal quality factors from planet‐induced stellar spin‐up
- Author
-
Ilić, Nikoleta, primary, Poppenhaeger, Katja, additional, Queiroz, Anna Barbara, additional, and Chiappini, Cristina, additional
- Published
- 2024
- Full Text
- View/download PDF
67. COVID-19 as a catalyst for reimagining cervical cancer prevention
- Author
-
Rebecca Luckett, Sarah Feldman, Yin Ling Woo, Anna-Barbara Moscicki, Anna R Giuliano, Silvia de Sanjosé, Andreas M Kaufmann, Shuk On Annie Leung, Francisco Garcia, Karen Chan, Neerja Bhatla, Margaret Stanley, Julia Brotherton, Joel Palefsky, Suzanne Garland, and on behalf of the International Papillomavirus Society (IPVS) Policy Committee
- Subjects
cervical cancer ,COVID19 ,global policy ,prevention ,vaccination ,HPV ,Medicine ,Science ,Biology (General) ,QH301-705.5 - Abstract
Cervical cancer has killed millions of women over the past decade. In 2019 the World Health Organization launched the Cervical Cancer Elimination Strategy, which included ambitious targets for vaccination, screening, and treatment. The COVID-19 pandemic disrupted progress on the strategy, but lessons learned during the pandemic – especially in vaccination, self-administered testing, and coordinated mobilization on a global scale – may help with efforts to achieve its targets. However, we must also learn from the failure of the COVID-19 response to include adequate representation of global voices. Efforts to eliminate cervical cancer will only succeed if those countries most affected are involved from the very start of planning. In this article we summarize innovations and highlight missed opportunities in the COVID response, and make recommendations to leverage the COVID experience to accelerate the elimination of cervical cancer globally.
- Published
- 2023
- Full Text
- View/download PDF
68. Futures Studies for Design Systems and Social Transformation from Time/Space-Based Perspectives
- Author
-
Anna Barbara and Yuemei Ma
- Subjects
time/space-based design ,design futures ,social transformation ,chronotope ,design systems ,Systems engineering ,TA168 ,Technology (General) ,T1-995 - Abstract
Analyses of disciplines encompassing futures studies reveal a prevailing tendency to perceive time as a linear sequence of projections. However, this perspective is not applicable to the current context of social transformation in the age of globalization and digitization, such as sustainable development. Preliminary investigations into time-based design and futures studies have shown the potential of time-based paradigms for predicting reliable future scenarios and redesigning current forms of spaces, relationships, and services in response to these desired futures. In this paper, we describe a project of an Ephemeral and Temporary Space Design Laboratory, which has been a pedagogical experiment for 3 years to date in the School of Design at the Politecnico di Milano. The objective of this project is to systematically design an area of the city by reflecting on the relationship between design systems and social change, using participatory design methods such as field research and interviews with local residents to systematically redesign the urban space of the Lodi/Corvetto area in the city of Milan. This research aims to investigate the systematic influence of time factors on the spatial design of urban communities through futuristic and time/space-based design perspectives. The findings demonstrate that the utilization of time-based paradigms and tools can effectively enhance the time-based design approach, resulting in its increased integration within the design process. This integration plays a pivotal role in the construction of systems that have the capability to interact with and catalyze social transformation within the broader public and shared community.
- Published
- 2023
- Full Text
- View/download PDF
69. κ-Carrageenan and PVA blends as bioinks to 3D print scaffolds for cartilage reconstruction
- Author
-
Muscolino, Emanuela, Di Stefano, Anna Barbara, Trapani, Marco, Sabatino, Maria Antonietta, Giacomazza, Daniela, Alessi, Sabina, Cammarata, Emanuele, Moschella, Francesco, Cordova, Adriana, Toia, Francesca, and Dispenza, Clelia
- Published
- 2022
- Full Text
- View/download PDF
70. In vitro and in vivo evidence that the switch from calcineurin to mTOR inhibitors may be a strategy for immunosuppression in Epstein–Barr virus–associated post-transplant lymphoproliferative disorder
- Author
-
Thieme, Constantin J., Schulz, Malissa, Wehler, Patrizia, Anft, Moritz, Amini, Leila, Blàzquez-Navarro, Arturo, Stervbo, Ulrik, Hecht, Jochen, Nienen, Mikalai, Stittrich, Anna-Barbara, Choi, Mira, Zgoura, Panagiota, Viebahn, Richard, Schmueck-Henneresse, Michael, Reinke, Petra, Westhoff, Timm H., Roch, Toralf, and Babel, Nina
- Published
- 2022
- Full Text
- View/download PDF
71. Analysis of MSCs' secretome and EVs cargo: Evaluation of functions and applications
- Author
-
Urrata, Valentina, Trapani, Marco, Franza, Mara, Moschella, Francesco, Di Stefano, Anna Barbara, and Toia, Francesca
- Published
- 2022
- Full Text
- View/download PDF
72. Vaginal microbiome and cervical cancer
- Author
-
Kyrgiou, Maria and Moscicki, Anna-Barbara
- Published
- 2022
- Full Text
- View/download PDF
73. Renal Function in Patients Hospitalized With Anorexia Nervosa Undergoing Refeeding: Findings From the Study of Refeeding to Optimize Inpatient Gains
- Author
-
Downey, Amanda E., Cheng, Jing, Adams, Sally H., Buckelew, Sara M., Kapphahn, Cynthia J., Machen, Vanessa I., Rosen, Elaine L., Moscicki, Anna-Barbara, Golden, Neville H., and Garber, Andrea K.
- Published
- 2022
- Full Text
- View/download PDF
74. Bayesian Variable Selection for Multivariate Zero-Inflated Models: Application to Microbiome Count Data
- Author
-
Lee, Kyu Ha, Coull, Brent A., Moscicki, Anna-Barbara, Paster, Bruce J., and Starr, Jacqueline R.
- Subjects
Statistics - Applications - Abstract
Microorganisms play critical roles in human health and disease. It is well known that microbes live in diverse communities in which they interact synergistically or antagonistically. Thus for estimating microbial associations with clinical covariates, multivariate statistical models are preferred. Multivariate models allow one to estimate and exploit complex interdependencies among multiple taxa, yielding more powerful tests of exposure or treatment effects than application of taxon-specific univariate analyses. In addition, the analysis of microbial count data requires special attention because data commonly exhibit zero inflation. To meet these needs, we developed a Bayesian variable selection model for multivariate count data with excess zeros that incorporates information on the covariance structure of the outcomes (counts for multiple taxa), while estimating associations with the mean levels of these outcomes. Although there has been a great deal of effort in zero-inflated models for longitudinal data, little attention has been given to high-dimensional multivariate zero-inflated data modeled via a general correlation structure. Through simulation, we compared performance of the proposed method to that of existing univariate approaches, for both the binary and count parts of the model. When outcomes were correlated the proposed variable selection method maintained type I error while boosting the ability to identify true associations in the binary component of the model. For the count part of the model, in some scenarios the the univariate method had higher power than the multivariate approach. This higher power was at a cost of a highly inflated false discovery rate not observed with the proposed multivariate method. We applied the approach to oral microbiome data from the Pediatric HIV/AIDS Cohort Oral Health Study and identified five species (of 44) associated with HIV infection.
- Published
- 2017
75. Test seeking: are healthcare professionals referring people to blood centers for infections marker testing?
- Author
-
Moreno, Elizabeth C, Bruhn, Roberta, Sabino, Ester C, Bolina-Santos, Eduarda, Miranda, Carolina, Carneiro-Proietti, Anna Barbara, Lopes, Maria Esther, de Almeida-Neto, Cesar, Loureiro, Paula, Capuani, Ligia, Takecian, Pedro L, Custer, Brian, and Gonçalez, Thelma T
- Subjects
Biomedical and Clinical Sciences ,Clinical Sciences ,HIV/AIDS ,Health Services ,Behavioral and Social Science ,Clinical Research ,Infectious Diseases ,8.1 Organisation and delivery of services ,Health and social care services research ,Infection ,Good Health and Well Being ,Blood donation ,Healthcare professionals ,Test-seeking ,Cardiovascular medicine and haematology - Abstract
BackgroundTest-seeking is associated with HIV in Brazilian blood donors. This study sought to investigate the frequency with which three different donor groups: deferred donors, accepted donors who tested HIV positive [HIV (+)], and accepted donors who tested infectious disease markers negative [IDM (-)], came to the blood bank at the suggestion of a health care professional.Study design and methodsDonors deferred for reporting high-risk behaviors and participants in an HIV risk factor case-control study completed a confidential audio computer-assisted self-interview (ACASI) that included two questions related to health care professionals and test-seeking.ResultsOf 4013 enrolled deferred donors, 468 (11.8%) reported a health care professional suggested donation as a way to be tested for infection. Of 341 HIV (+) and 791 IDM (-) participants, 43 (12.6%) and 11 (1.4%), respectively, reported a health care professional suggested donation as a way to be tested for infection. Physicians were the most frequently reported source of referral: [(61.5% of deferred, 69.1% of HIV (+), and 9.1% of IDM (-) donors)].ConclusionHIV (+) donors and deferred donors were 10 times more likely to report test-seeking behavior by suggestion of health care professional than IDM (-) donors. If true, efforts should be made to educate health care professionals and blood donors on how to safeguard the blood supply, emphasizing that HIV testing should be done at volunteer testing centers rather than at the blood centers.
- Published
- 2019
76. A prospective, single-arm, open-label, non-randomized, phase IIa trial of a nonavalent prophylactic HPV vaccine to assess immunogenicity of a prime and deferred-booster dosing schedule among 9-11 year-old girls and boys - clinical protocol.
- Author
-
Zeng, Yi, Moscicki, Anna-Barbara, Sahasrabuddhe, Vikrant, Garcia, Francisco, Woo, Heide, Hsu, Chiu-Hsieh, Szabo, Eva, Dimond, Eileen, Vanzzini, Susan, Mondragon, Angelica, Butler, Valerie, DeRose, Hillary, and Chow, H-H
- Subjects
Cervical cancer ,Gardasil 9 ,HPV vaccine ,Human papillomavirus ,Nonavalent HPV vaccine ,Serologic geometric mean titer ,Antibodies ,Viral ,Child ,Female ,Humans ,Immunization Schedule ,Immunogenicity ,Vaccine ,Male ,Papillomavirus Infections ,Papillomavirus Vaccines ,Prospective Studies ,Treatment Outcome - Abstract
BACKGROUND: Human papillomavirus (HPV) vaccines are indicated for the prevention of cancers and genital warts caused by vaccine-covered HPV types. Although the standard regimen requires a two or three-dose vaccine series, there is emerging data suggesting that a single dose of the bivalent or quadrivalent HPV vaccine generates persistently positive antibody titers. No similar data is yet available for the nonavalent HPV vaccine, currently the only HPV vaccine available in the United States. The overall objective of our study is to assess the stability and kinetics of antibody titers for 24 months following a single dose of the nonavalent HPV vaccine among preteen girls and boys. METHODS: This is a prospective, single-arm, open-label, non-randomized, Phase IIa trial among 9-11 year-old girls and boys to determine the immunogenicity after a single dose of the nonavalent HPV vaccine (GARDASIL® 9) over 24 months, with a deferred booster dose at 24 months and an optional booster at 30 months after the first dose. Participants provide blood specimens at 6, 12, 18, 24, and 30 months after the first dose. Serologic geometric mean titers (GMT) of the nine vaccine types (HPV 16/18/ 6/11/31/33/45/52/58) will be measured at each time point. The primary objective is to determine the stability of type-specific serologic GMT of HPV16 and HPV18 between the 6- vs. 12-month, 12- vs. 18-month, and 18- vs. 24-month visits. Secondary objectives are to determine the stability of type-specific serologic GMT of the other HPV types (HPV 6/11/31/33/45/52/58) between the visits and to assess safety and reactogenicity after each vaccine dose. DISCUSSION: Single dose HPV vaccination could simplify the logistics and reduce costs of HPV vaccination in the US and across the world. This study will contribute important immunogenicity data on the stability and kinetics of type-specific antibody titers and inform feasibility of the single dose HPV vaccination paradigm. TRIAL REGISTRATION: ClinicalTrials.gov Identifier: NCT02568566 . Registered on October 6, 2015.
- Published
- 2019
77. Toll-like receptors: Important immune checkpoints in the regression of cervical intra-epithelial neoplasia 2.
- Author
-
Halec, Gordana, Scott, Mark, Farhat, Sepideh, Moscicki, Anna-Barbara, and Darragh, Teresa
- Subjects
CIN2 regression ,Toll-like receptors ,cervical intra-epithelial neoplasia 2 ,human papillomavirus ,Adolescent ,Adult ,Cervix Uteri ,Female ,Humans ,Papillomaviridae ,Papillomavirus Infections ,Toll-Like Receptors ,Uterine Cervical Neoplasms ,Vaginal Smears ,Young Adult ,Uterine Cervical Dysplasia - Abstract
Toll-like receptors (TLRs) are innate immune defenders thought to be critical for the clearance of human papillomavirus (HPV) infections hence preventing the development of HPV-associated high-grade cervical intra-epithelial neoplasia (CIN2 or 3), a potential cervical cancer precursor. However, the role of TLRs in the regression of established cervical lesions, such as CIN2, is hindered by a lack of prospective design studies. Using SYBR green real-time PCR assays, we have examined the gene expression of TLR2, TLR3, TLR7, TLR8 and TLR9, in cytobrush collected endocervical cells of 63 women diagnosed with CIN2 at study entry (baseline) and followed over a 3-year period. Wilcoxon rank-sum test was used to examine the association between TLR expression levels, measured at baseline, and CIN2 outcome (regression vs. persistence/progression) over time. HPV genotyping was performed using Roche Linear Array Assay detecting 37 HPV types. Women with CIN2 regression showed significantly higher baseline levels of TLR2 (p = 0.006) and TLR7 (p = 0.007), as well as a non-significant trend for a higher TLR8 expression (p = 0.053) compared to women with CIN2 persistence/progression. Six women with CIN2 regression, who presented with an HR-HPV DNA-negative CIN2 lesion at study entry, had significantly higher baseline levels of TLR2 (p = 0.005), TLR7 (p = 0.013) and TLR8 (p = 0.012), compared to women with CIN2 persistence/progression, suggesting their role in clearance of HPV prior to clearance of the lesion. Our results confirm a key role of TLRs in regression of CIN2 and support the potential use of TLR-agonists for treatment of these lesions.
- Published
- 2018
78. The association between oral disease and type of antiretroviral therapy among perinatally HIV-infected youth
- Author
-
Shiboski, Caroline H, Yao, Tzy-Jyun, Russell, Jonathan S, Ryder, Mark I, Van Dyke, Russell B, Seage, George R, and Moscicki, Anna-Barbara
- Subjects
Infectious Diseases ,Clinical Research ,Dental/Oral and Craniofacial Disease ,Clinical Trials and Supportive Activities ,Pediatric ,HIV/AIDS ,Evaluation of treatments and therapeutic interventions ,6.1 Pharmaceuticals ,Infection ,Oral and gastrointestinal ,Good Health and Well Being ,Adolescent ,Anti-Retroviral Agents ,Antiretroviral Therapy ,Highly Active ,CD4 Lymphocyte Count ,Cross-Sectional Studies ,Female ,HIV Infections ,Humans ,Male ,Periodontal Diseases ,Stomatognathic Diseases ,Viral Load ,Young Adult ,caries ,combination antiretroviral therapy ,HIV ,oral disease ,Pediatric HIV/AIDS Cohort Study ,Biological Sciences ,Medical and Health Sciences ,Psychology and Cognitive Sciences ,Virology - Abstract
ObjectivesThis study explores the association between combination antiretroviral therapy (cART) and oral health outcomes (dental and periodontal) among perinatally HIV-infected (PHIV) youth.MethodsWe conducted a cross-sectional study of oral health among PHIV youth participating in the Oral Health substudy of the Pediatric HIV/AIDS Cohort Study (PHACS). Dentists at research sites were trained/calibrated on how to perform a standardized oral mucosal, dental and periodontal examination. They assessed the decayed-missing-filled-surfaces and teeth index (DMFS/T). The number of decayed surfaces and teeth and the number of teeth with gingival bleeding on probing for each participant were derived from the examination. Data for analysis included lifetime measurements of CD4 cell count and viral load, sociodemographic information and current/past history of ART.ResultsAmong 209 PHIV youth, 95% were on ART at the time of enrolment. Among 143 PHIV youth on the same cART for at least 1 year, we found that the mean decayed teeth score of those receiving cART containing an integrase inhibitor was 86% higher than that of those on cART without an integrase inhibitor after adjusting for age, lifetime proportion of unsuppressed viral load and CD4 cell count nadir. Initiating protease inhibitors before age 6 years was associated with a significantly lower DMFT score than participants who initiated at age 6 years and older.ConclusionOur study revealed that PHIV youth who received cART containing an integrase inhibitor had a significantly higher number of untreated active caries than those on cART without an integrase inhibitor. This may warrant closer dental surveillance of those receiving an integrase inhibitor.
- Published
- 2018
79. Einleitung
- Author
-
Orschulik, Anna Barbara, Kaiser, Gabriele, Series Editor, and Orschulik, Anna Barbara
- Published
- 2021
- Full Text
- View/download PDF
80. Organic aerosol source apportionment by using rolling positive matrix factorization: Application to a Mediterranean coastal city
- Author
-
Chazeau, Benjamin, El Haddad, Imad, Canonaco, Francesco, Temime-Roussel, Brice, D'Anna, Barbara, Gille, Grégory, Mesbah, Boualem, Prévôt, André S.H., Wortham, Henri, and Marchand, Nicolas
- Published
- 2022
- Full Text
- View/download PDF
81. A case study and proposal for publishing directed acyclic graphs: The effectiveness of the quadrivalent human papillomavirus vaccine in perinatally HIV Infected girls
- Author
-
Barnard-Mayers, Ruby, Kouser, Hiba, Cohen, Jamie A., Tassiopoulos, Katherine, Caniglia, Ellen C., Moscicki, Anna-Barbara, Campos, Nicole G., Caunca, Michelle R., Seage, George R. Seage, and Murray, Eleanor J
- Published
- 2022
- Full Text
- View/download PDF
82. Association between inflammatory molecules, nitric oxide metabolites and leg ulcers in individuals with sickle cell anemia
- Author
-
Belisário, André Rolim, Mendes-Oliveira, Franciane, de Souza, Valquíria Reis, Bolina-Santos, Eduarda, Mendes, Fabíola Gomes, Moreno, Elizabeth Castro, Franca, Alice Timponi, Sabino, Ester Cerdeira, Otta, Dayane Andriotti, de Faria, Elaine Speziali, Coelho-dos-Reis, Jordana Grazziela Alves, Martins-Filho, Olindo Assis, and Carneiro-Proietti, Anna Bárbara
- Published
- 2022
- Full Text
- View/download PDF
83. A mulher na sociedade de classes : um clássico dos estudos de gênero
- Author
-
Sorj, Bila and Araujo, Anna Bárbara
- Published
- 2021
84. The Fourteenth Data Release of the Sloan Digital Sky Survey: First Spectroscopic Data from the extended Baryon Oscillation Spectroscopic Survey and from the second phase of the Apache Point Observatory Galactic Evolution Experiment
- Author
-
Abolfathi, Bela, Aguado, D. S., Aguilar, Gabriela, Prieto, Carlos Allende, Almeida, Andres, Ananna, Tonima Tasnim, Anders, Friedrich, Anderson, Scott F., Andrews, Brett H., Anguiano, Borja, Aragon-Salamanca, Alfonso, Argudo-Fernandez, Maria, Armengaud, Eric, Ata, Metin, Aubourg, Eric, Avila-Reese, Vladimir, Badenes, Carles, Bailey, Stephen, Balland, Christophe, Barger, Kathleen A., Barrera-Ballesteros, Jorge, Bartosz, Curtis, Bastien, Fabienne, Bates, Dominic, Baumgarten, Falk, Bautista, Julian, Beaton, Rachael, Beers, Timothy C., Belfiore, Francesco, Bender, Chad F., Bernardi, Mariangela, Bershady, Matthew A., Beutler, Florian, Bird, Jonathan C., Bizyaev, Dmitry, Blanc, Guillermo A., Blanton, Michael R., Blomqvist, Michael, Bolton, Adam S., Boquien, Mederic, Borissova, Jura, Bovy, Jo, Diaz, Christian Andres Bradna, Brandt, William Nielsen, Brinkmann, Jonathan, Brownstein, Joel R., Bundy, Kevin, Burgasser, Adam J., Burtin, Etienne, Busca, Nicolas G., Canas, Caleb I., Cano-Diaz, Mariana, Cappellari, Michele, Carrera, Ricardo, Casey, Andrew R., Sodi, Bernardo Cervantes, Chen, Yanping, Cherinka, Brian, Chiappini, Cristina, Choi, Peter Doohyun, Chojnowski, Drew, Chuang, Chia-Hsun, Chung, Haeun, Clerc, Nicolas, Cohen, Roger E., Comerford, Julia M., Comparat, Johan, Nascimento, Janaina Correa do, da Costa, Luiz, Cousinou, Marie-Claude, Covey, Kevin, Crane, Jeffrey D., Cruz-Gonzalez, Irene, Cunha, Katia, Ilha, Gabriele da Silva, Damke, Guillermo J., Darling, Jeremy, Davidson Jr., James W., Dawson, Kyle, Lizaola, Miguel Angel C. de Icaza, de la Macorra, Axel, de la Torre, Sylvain, De Lee, Nathan, Agathe, Victoria de Sainte, Machado, Alice Deconto, Dell'Agli, Flavia, Delubac, Timothee, Diamond-Stanic, Aleksandar M., Donor, John, Downes, Juan Jose, Drory, Niv, Bourboux, Helion du Mas des, Duckworth, Christopher J., Dwelly, Tom, Dyer, Jamie, Ebelke, Garrett, Eigenbrot, Arthur Davis, Eisenstein, Daniel J., Elsworth, Yvonne P., Emsellem, Eric, Eracleous, Mike, Erfanianfar, Ghazaleh, Escoffier, Stephanie, Fan, Xiaohui, Alvar, Emma Fernandez, Fernandez-Trincado, J. G., Cirolini, Rafael Fernando, Feuillet, Diane, Finoguenov, Alexis, Fleming, Scott W., Font-Ribera, Andreu, Freischlad, Gordon, Frinchaboy, Peter, Fu, Hai, Chew, Yilen Gomez Maqueo, Galbany, Lluis, Perez, Ana E. Garcia, Garcia-Dias, R., Garcia-Hernandez, D. A., Oehmichen, Luis Alberto Garma, Gaulme, Patrick, Gelfand, Joseph, Gil-Marin, Hector, Gillespie, Bruce A., Goddard, Daniel, Hernandez, Jonay I. Gonzalez, Gonzalez-Perez, Violeta, Grabowski, Kathleen, Green, Paul J., Grier, Catherine J., Gueguen, Alain, Guo, Hong, Guy, Julien, Hagen, Alex, Hall, Patrick, Harding, Paul, Hasselquist, Sten, Hawley, Suzanne, Hayes, Christian R., Hearty, Fred, Hekker, Saskia, Hernandez, Jesus, Toledo, Hector Hernandez, Hogg, David W., Holley-Bockelmann, Kelly, Holtzman, Jon, Hou, Jiamin, Hsieh, Bau-Ching, Hunt, Jason A. S., Hutchinson, Timothy A., Hwang, Ho Seong, Angel, Camilo Eduardo Jimenez, Johnson, Jennifer A., Jones, Amy, Jonsson, Henrik, Jullo, Eric, Khan, Fahim Sakil, Kinemuchi, Karen, Kirkby, David, Kirkpatrick IV, Charles C., Kitaura, Francisco-Shu, Knapp, Gillian R., Kneib, Jean-Paul, Kollmeier, Juna A., Lacerna, Ivan, Lane, Richard R., Lang, Dustin, Law, David R., Goff, Jean-Marc Le, Lee, Young-Bae, Li, Hongyu, Li, Cheng, Lian, Jianhui, Liang, Yu, Lima, Marcos, Lin, Lihwai, Long, Dan, Lucatello, Sara, Lundgren, Britt, Mackereth, J. Ted, MacLeod, Chelsea L., Mahadevan, Suvrath, Maia, Marcio Antonio Geimba, Majewski, Steven, Manchado, Arturo, Maraston, Claudia, Mariappan, Vivek, Marques-Chaves, Rui, Masseron, Thomas, Masters, Karen L., McDermid, Richard M., McGreer, Ian D., Melendez, Matthew, Meneses-Goytia, Sofia, Merloni, Andrea, Merrifield, Michael R., Meszaros, Szabolcs, Meza, Andres, Minchev, Ivan, Minniti, Dante, Mueller, Eva-Maria, Muller-Sanchez, Francisco, Muna, Demitri, Munoz, Ricardo R., Myers, Adam D., Nair, Preethi, Nandra, Kirpal, Ness, Melissa, Newman, Jeffrey A., Nichol, Robert C., Nidever, David L., Nitschelm, Christian, Noterdaeme, Pasquier, O'Connell, Julia, Oelkers, Ryan James, Oravetz, Audrey, Oravetz, Daniel, Ortiz, Erik Aquino, Osorio, Yeisson, Pace, Zach, Padilla, Nelson, Palanque-Delabrouille, Nathalie, Palicio, Pedro Alonso, Pan, Hsi-An, Pan, Kaike, Parikh, Taniya, Paris, Isabelle, Park, Changbom, Peirani, Sebastien, Pellejero-Ibanez, Marcos, Penny, Samantha, Percival, Will J., Perez-Fournon, Ismael, Petitjean, Patrick, Pieri, Matthew M., Pinsonneault, Marc, Pisani, Alice, Prada, Francisco, Prakash, Abhishek, Queiroz, Anna Barbara de Andrade, Raddick, M. Jordan, Raichoor, Anand, Rembold, Sandro Barboza, Richstein, Hannah, Riffel, Rogemar A., Riffel, Rogerio, Rix, Hans-Walter, Robin, Annie C., Torres, Sergio Rodriguez, Roman-Zuniga, Carlos, Ross, Ashley J., Rossi, Graziano, Ruan, John, Ruggeri, Rossana, Ruiz, Jose, Salvato, Mara, Sanchez, Ariel G., Sanchez, Sebastian F., Almeida, Jorge Sanchez, Sanchez-Gallego, Jose R., Rojas, Felipe Antonio Santana, Santiago, Basilio Xavier, Schiavon, Ricardo P., Schimoia, Jaderson S., Schlafly, Edward, Schlegel, David, Schneider, Donald P., Schuster, William J., Schwope, Axel, Seo, Hee-Jong, Serenelli, Aldo, Shen, Shiyin, Shen, Yue, Shetrone, Matthew, Shull, Michael, Aguirre, Victor Silva, Simon, Joshua D., Skrutskie, Mike, Slosar, Anze, Smethurst, Rebecca, Smith, Verne, Sobeck, Jennifer, Somers, Garrett, Souter, Barbara J., Souto, Diogo, Spindler, Ashley, Stark, David V., Stassun, Keivan, Steinmetz, Matthias, Stello, Dennis, Storchi-Bergmann, Thaisa, Streblyanska, Alina, Stringfellow, Guy, Suarez, Genaro, Sun, Jing, Szigeti, Laszlo, Taghizadeh-Popp, Manuchehr, Talbot, Michael S., Tang, Baitian, Tao, Charling, Tayar, Jamie, Tembe, Mita, Teske, Johanna, Thaker, Aniruddha R., Thomas, Daniel, Tissera, Patricia, Tojeiro, Rita, Tremonti, Christy, Troup, Nicholas W., Urry, Meg, Valenzuela, O., Bosch, Remco van den, Vargas-Gonzalez, Jaime, Vargas-Magana, Mariana, Vazquez, Jose Alberto, Villanova, Sandro, Vogt, Nicole, Wake, David, Wang, Yuting, Weaver, Benjamin Alan, Weijmans, Anne-Marie, Weinberg, David H., Westfall, Kyle B., Whelan, David G., Wilcots, Eric, Wild, Vivienne, Williams, Rob A., Wilson, John, Wood-Vasey, W. M., Wylezalek, Dominika, Xiao, Ting, Yan, Renbin, Yang, Meng, Ybarra, Jason E., Yeche, Christophe, Zakamska, Nadia, Zamora, Olga, Zarrouk, Pauline, Zasowski, Gail, Zhang, Kai, Zhao, Cheng, Zhao, Gong-Bo, Zheng, Zheng, Zhou, Zhi-Min, Zhu, Guangtun, Zinn, Joel C., and Zou, Hu
- Subjects
Astrophysics - Astrophysics of Galaxies ,Astrophysics - Instrumentation and Methods for Astrophysics - Abstract
The fourth generation of the Sloan Digital Sky Survey (SDSS-IV) has been in operation since July 2014. This paper describes the second data release from this phase, and the fourteenth from SDSS overall (making this, Data Release Fourteen or DR14). This release makes public data taken by SDSS-IV in its first two years of operation (July 2014-2016). Like all previous SDSS releases, DR14 is cumulative, including the most recent reductions and calibrations of all data taken by SDSS since the first phase began operations in 2000. New in DR14 is the first public release of data from the extended Baryon Oscillation Spectroscopic Survey (eBOSS); the first data from the second phase of the Apache Point Observatory (APO) Galactic Evolution Experiment (APOGEE-2), including stellar parameter estimates from an innovative data driven machine learning algorithm known as "The Cannon"; and almost twice as many data cubes from the Mapping Nearby Galaxies at APO (MaNGA) survey as were in the previous release (N = 2812 in total). This paper describes the location and format of the publicly available data from SDSS-IV surveys. We provide references to the important technical papers describing how these data have been taken (both targeting and observation details) and processed for scientific use. The SDSS website (www.sdss.org) has been updated for this release, and provides links to data downloads, as well as tutorials and examples of data use. SDSS-IV is planning to continue to collect astronomical data until 2020, and will be followed by SDSS-V., Comment: SDSS-IV collaboration alphabetical author data release paper. DR14 happened on 31st July 2017. 19 pages, 5 figures. Accepted by ApJS on 28th Nov 2017 (this is the "post-print" and "post-proofs" version; minor corrections only from v1, and most of errors found in proofs corrected)
- Published
- 2017
- Full Text
- View/download PDF
85. Sloan Digital Sky Survey IV: Mapping the Milky Way, Nearby Galaxies, and the Distant Universe
- Author
-
Blanton, Michael R., Bershady, Matthew A., Abolfathi, Bela, Albareti, Franco D., Prieto, Carlos Allende, Almeida, Andres, Alonso-García, Javier, Anders, Friedrich, Anderson, Scott F., Andrews, Brett, Aquino-Ortíz, Erik, Aragón-Salamanca, Alfonso, Argudo-Fernández, Maria, Armengaud, Eric, Aubourg, Eric, Avila-Reese, Vladimir, Badenes, Carles, Bailey, Stephen, Barger, Kathleen A., Barrera-Ballesteros, Jorge, Bartosz, Curtis, Bates, Dominic, Baumgarten, Falk, Bautista, Julian, Beaton, Rachael, Beers, Timothy C., Belfiore, Francesco, Bender, Chad F., Berlind, Andreas A., Bernardi, Mariangela, Beutler, Florian, Bird, Jonathan C., Bizyaev, Dmitry, Blanc, Guillermo A., Blomqvist, Michael, Bolton, Adam S., Boquien, Médéric, Borissova, Jura, Bosch, Remco van den, Bovy, Jo, Brandt, William N., Brinkmann, Jonathan, Brownstein, Joel R., Bundy, Kevin, Burgasser, Adam J., Burtin, Etienne, Busca, Nicolás G., Cappellari, Michele, Carigi, Maria Leticia Delgado, Carlberg, Joleen K., Rosell, Aurelio Carnero, Carrera, Ricardo, Cherinka, Brian, Cheung, Edmond, Chew, Yilen Gómez Maqueo, Chiappini, Cristina, Choi, Peter Doohyun, Chojnowski, Drew, Chuang, Chia-Hsun, Chung, Haeun, Cirolini, Rafael Fernando, Clerc, Nicolas, Cohen, Roger E., Comparat, Johan, da Costa, Luiz, Cousinou, Marie-Claude, Covey, Kevin, Crane, Jeffrey D., Croft, Rupert A. C., Cruz-Gonzalez, Irene, Cuadra, Daniel Garrido, Cunha, Katia, Damke, Guillermo J., Darling, Jeremy, Davies, Roger, Dawson, Kyle, de la Macorra, Axel, De Lee, Nathan, Delubac, Timothée, Di Mille, Francesco, Diamond-Stanic, Aleks, Cano-Díaz, Mariana, Donor, John, Downes, Juan José, Drory, Niv, Bourboux, Hélion du Mas des, Duckworth, Christopher J., Dwelly, Tom, Dyer, Jamie, Ebelke, Garrett, Eisenstein, Daniel J., Emsellem, Eric, Eracleous, Mike, Escoffier, Stephanie, Evans, Michael L., Fan, Xiaohui, Fernández-Alvar, Emma, Fernandez-Trincado, J. G., Feuillet, Diane K., Finoguenov, Alexis, Fleming, Scott W., Font-Ribera, Andreu, Fredrickson, Alexander, Freischlad, Gordon, Frinchaboy, Peter M., Galbany, Lluís, Garcia-Dias, R., García-Hernández, D. A., Gaulme, Patrick, Geisler, Doug, Gelfand, Joseph D., Gil-Marín, Héctor, Gillespie, Bruce A., Goddard, Daniel, Gonzalez-Perez, Violeta, Grabowski, Kathleen, Green, Paul J., Grier, Catherine J., Gunn, James E., Guo, Hong, Guy, Julien, Hagen, Alex, Hahn, ChangHoon, Hall, Matthew, Harding, Paul, Hasselquist, Sten, Hawley, Suzanne L., Hearty, Fred, Hernández, Jonay I. Gonzalez, Ho, Shirley, Hogg, David W., Holley-Bockelmann, Kelly, Holtzman, Jon A., Holzer, Parker H., Huehnerhoff, Joseph, Hutchinson, Timothy A., Hwang, Ho Seong, Ibarra-Medel, Héctor J., Ilha, Gabriele da Silva, Ivans, Inese I., Ivory, KeShawn, Jackson, Kelly, Jensen, Trey W., Johnson, Jennifer A., Jones, Amy, Jönsson, Henrik, Jullo, Eric, Kamble, Vikrant, Kinemuchi, Karen, Kirkby, David, Kitaura, Francisco-Shu, Klaene, Mark, Knapp, Gillian R., Kneib, Jean-Paul, Kollmeier, Juna A., Lacerna, Ivan, Lane, Richard R., Lang, Dustin, Law, David R., Lazarz, Daniel, Goff, Jean-Marc Le, Liang, Fu-Heng, Li, Cheng, LI, Hongyu, Lima, Marcos, Lin, Lihwai, Lin, Yen-Ting, de Lis, Sara Bertran, Liu, Chao, Lizaola, Miguel Angel C. de Icaza, Long, Dan, Lucatello, Sara, Lundgren, Britt, MacDonald, Nicholas K., Machado, Alice Deconto, MacLeod, Chelsea L., Mahadevan, Suvrath, Maia, Marcio Antonio Geimba, Maiolino, Roberto, Majewski, Steven R., Malanushenko, Elena, Malanushenko, Viktor, Manchado, Arturo, Mao, Shude, Maraston, Claudia, Marques-Chaves, Rui, Masters, Karen L., McBride, Cameron K., McDermid, Richard M., McGrath, Brianne, McGreer, Ian D., Peña, Nicolás Medina, Melendez, Matthew, Merloni, Andrea, Merrifield, Michael R., Meszaros, Szabolcs, Meza, Andres, Minchev, Ivan, Minniti, Dante, Miyaji, Takamitsu, More, Surhud, Mulchaey, John, Müller-Sánchez, Francisco, Muna, Demitri, Munoz, Ricardo R., Myers, Adam D., Nair, Preethi, Nandra, Kirpal, Nascimento, Janaina Correa do, Negrete, Alenka, Ness, Melissa, Newman, Jeffrey A., Nichol, Robert C., Nidever, David L., Nitschelm, Christian, Ntelis, Pierros, O'Connell, Julia E., Oelkers, Ryan J., Oravetz, Audrey, Oravetz, Daniel, Pace, Zach, Padilla, Nelson, Palanque-Delabrouille, Nathalie, Palicio, Pedro Alonso, Pan, Kaike, Parikh, Taniya, Pâris, Isabelle, Park, Changbom, Patten, Alim Y., Peirani, Sebastien, Pellejero-Ibanez, Marcos, Penny, Samantha, Percival, Will J., Perez-Fournon, Ismael, Petitjean, Patrick, Pieri, Matthew M., Pinsonneault, Marc, Pisani, Alice, Poleski, Radosław, Prada, Francisco, Prakash, Abhishek, Queiroz, Anna Bárbara de Andrade, Raddick, M. Jordan, Raichoor, Anand, Rembold, Sandro Barboza, Richstein, Hannah, Riffel, Rogemar A., Riffel, Rogério, Rix, Hans-Walter, Robin, Annie C., Rockosi, Constance M., Rodríguez-Torres, Sergio, Roman-Lopes, A., Román-Zúñiga, Carlos, Rosado, Margarita, Ross, Ashley J., Rossi, Graziano, Ruan, John, Ruggeri, Rossana, Rykoff, Eli S., Salazar-Albornoz, Salvador, Salvato, Mara, Sánchez, Ariel G., Aguado, David Sánchez, Sánchez-Gallego, José R., Santana, Felipe A., Santiago, Basílio Xavier, Sayres, Conor, Schiavon, Ricardo P., Schimoia, Jaderson da Silva, Schlafly, Edward F., Schlegel, David J., Schneider, Donald P., Schultheis, Mathias, Schuster, William J., Schwope, Axel, Seo, Hee-Jong, Shao, Zhengyi, Shen, Shiyin, Shetrone, Matthew, Shull, Michael, Simon, Joshua D., Skinner, Danielle, Skrutskie, M. F., Slosar, Anže, Smith, Verne V., Sobeck, Jennifer S., Sobreira, Flavia, Somers, Garrett, Souto, Diogo, Stark, David V., Stassun, Keivan, Stauffer, Fritz, Steinmetz, Matthias, Storchi-Bergmann, Thaisa, Streblyanska, Alina, Stringfellow, Guy S., Suárez, Genaro, Sun, Jing, Suzuki, Nao, Szigeti, Laszlo, Taghizadeh-Popp, Manuchehr, Tang, Baitian, Tao, Charling, Tayar, Jamie, Tembe, Mita, Teske, Johanna, Thakar, Aniruddha R., Thomas, Daniel, Thompson, Benjamin A., Tinker, Jeremy L., Tissera, Patricia, Tojeiro, Rita, Toledo, Hector Hernandez, de la Torre, Sylvain, Tremonti, Christy, Troup, Nicholas W., Valenzuela, Octavio, Valpuesta, Inma Martinez, Vargas-González, Jaime, Vargas-Magaña, Mariana, Vazquez, Jose Alberto, Villanova, Sandro, Vivek, M., Vogt, Nicole, Wake, David, Walterbos, Rene, Wang, Yuting, Weaver, Benjamin Alan, Weijmans, Anne-Marie, Weinberg, David H., Westfall, Kyle B., Whelan, David G., Wild, Vivienne, Wilson, John, Wood-Vasey, W. M., Wylezalek, Dominika, Xiao, Ting, Yan, Renbin, Yang, Meng, Ybarra, Jason E., Yèche, Christophe, Zakamska, Nadia, Zamora, Olga, Zarrouk, Pauline, Zasowski, Gail, Zhang, Kai, Zhao, Gong-Bo, Zheng, Zheng, Zhou, Zhi-Min, Zhu, Guangtun B., Zoccali, Manuela, and Zou, Hu
- Subjects
Astrophysics - Astrophysics of Galaxies - Abstract
We describe the Sloan Digital Sky Survey IV (SDSS-IV), a project encompassing three major spectroscopic programs. The Apache Point Observatory Galactic Evolution Experiment 2 (APOGEE-2) is observing hundreds of thousands of Milky Way stars at high resolution and high signal-to-noise ratio in the near-infrared. The Mapping Nearby Galaxies at Apache Point Observatory (MaNGA) survey is obtaining spatially-resolved spectroscopy for thousands of nearby galaxies (median redshift of z = 0.03). The extended Baryon Oscillation Spectroscopic Survey (eBOSS) is mapping the galaxy, quasar, and neutral gas distributions between redshifts z = 0.6 and 3.5 to constrain cosmology using baryon acoustic oscillations, redshift space distortions, and the shape of the power spectrum. Within eBOSS, we are conducting two major subprograms: the SPectroscopic IDentification of eROSITA Sources (SPIDERS), investigating X-ray AGN and galaxies in X-ray clusters, and the Time Domain Spectroscopic Survey (TDSS), obtaining spectra of variable sources. All programs use the 2.5-meter Sloan Foundation Telescope at Apache Point Observatory; observations there began in Summer 2014. APOGEE-2 also operates a second near-infrared spectrograph at the 2.5-meter du Pont Telescope at Las Campanas Observatory, with observations beginning in early 2017. Observations at both facilities are scheduled to continue through 2020. In keeping with previous SDSS policy, SDSS-IV provides regularly scheduled public data releases; the first one, Data Release 13, was made available in July 2016., Comment: Published in Astronomical Journal
- Published
- 2017
- Full Text
- View/download PDF
86. The Abundance and Sources of Ice Nucleating Particles Within Alaskan Ice Fog.
- Author
-
Lill, Emily, Costa, Emily J., Barry, Kevin, Mirrielees, Jessica A., Mashkevich, Monica, Wu, Judy, Holen, Andrew L., Cesler‐Maloney, Meeta, DeMott, Paul J., Perkins, Russell, Hill, Thomas, Sullivan, Amy, Levin, Ezra, Simpson, William R., Mao, Jingqiu, Temime‐Roussel, Brice, D'Anna, Barbara, Law, Kathy S., Ault, Andrew P., and Schmitt, Carl
- Abstract
The Alaskan Layered Pollution and Chemical Analysis (ALPACA) field campaign included deployment of a suite of atmospheric measurements in January–February 2022 with the goal of better understanding atmospheric processes and pollution under cold and dark conditions in Fairbanks, Alaska. We report on measurements of particle composition, particle size, ice nucleating particle (INP) composition, and INP size during an ice fog period (29 January–3 February). During this period, coarse particulate matter (PM10) concentrations increased by 150% in association with a decrease in air temperature, a stronger temperature inversion, and relatively stagnant conditions. Results also show a 18%–78% decrease in INPs during the ice fog period, indicating that particles had activated into the ice fog via nucleation. Peroxide and heat treatments performed on INPs indicated that, on average, the largest contributions to the INP population were heat‐labile (potentially biological, 63%), organic (31%), then inorganic (likely dust, 6%). Measurements of levoglucosan and bulk and single‐particle composition corroborate the presence of dust and aerosols from combustion sources. Heat‐labile and organic INPs decreased during the peak period of the ice fog, indicating those were preferentially activated, while inorganic INPs increased, suggesting they remained as interstitial INPs. In general, INP concentrations were unexpectedly high in Fairbanks compared to other locations in the Arctic during winter. The fact that these INPs likely facilitated ice fog formation in Fairbanks has implications for other high latitude locations subject to the hazards associated with ice fog. Plain Language Summary: The Alaskan Layered Pollution and Chemical Analysis field campaign occurred January–February 2022 with the goal of better understanding the atmosphere and atmospheric pollution during the winter in Fairbanks, Alaska. We studied a rare subset of atmospheric particles called ice nucleating particles which facilitate the formation of ice fog by allowing water to freeze at temperatures above −38°C. During our study, there was an ice fog event that coincided with a pollution event. During this event, there was a significant increase in coarse particulate matter associated with a decrease in temperature and calm winds. Ice nucleating particle concentration in the air decreased during the ice fog event indicating that the INPs had activated into the ice fog and were not able to be captured. We determined that most INPs were heat‐labile (potentially biological), followed by organic. Very few INPs were inorganic. Inorganic INPs increased during the ice fog period while heat‐labile and organic INPs decreased indicating that they were being selectively activated into the fog. Overall, INP concentrations in Fairbanks were quite high compared to other Arctic locations and carries implications for ice fog formation in other high‐latitude locations. Key Points: Fairbanks had higher wintertime ice nucleating particle (INP) concentrations than other high‐latitude locationsINP concentrations in Fairbanks decreased during the ice fog period, indicating that INPs were activated into the fogINP composition in Fairbanks was dominated by heat‐labile INPs [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
87. Neoadjuvant Intratumoral Immunotherapy with Cowpea Mosaic Virus Induces Local and Systemic Antitumor Efficacy in Canine Mammary Cancer Patients
- Author
-
Guillermo Valdivia, Daniel Alonso-Miguel, Maria Dolores Perez-Alenza, Anna Barbara Emilia Zimmermann, Evelien Schaafsma, Fred W. Kolling, Lucia Barreno, Angela Alonso-Diez, Veronique Beiss, Jessica Fernanda Affonso de Oliveira, María Suárez-Redondo, Steven Fiering, Nicole F. Steinmetz, Johannes vom Berg, Laura Peña, and Hugo Arias-Pulido
- Subjects
canine mammary cancer ,intratumoral immunotherapy ,plant virus ,cowpea mosaic virus ,nanoparticles ,immune cells ,Cytology ,QH573-671 - Abstract
The lack of optimal models to evaluate novel agents is delaying the development of effective immunotherapies against human breast cancer (BC). In this prospective open label study, we applied neoadjuvant intratumoral immunotherapy with empty cowpea mosaic virus-like particles (eCPMV) to 11 companion dogs diagnosed with canine mammary cancer (CMC), a spontaneous tumor resembling human BC. We found that two neoadjuvant intratumoral eCPMV injections resulted in tumor reduction in injected tumors in all patients and in noninjected tumors located in the ipsilateral and contralateral mammary chains of injected dogs. Tumor reduction was independent of clinical stage, tumor size, histopathologic grade, and tumor molecular subtype. RNA-seq-based analysis of injected tumors indicated a decrease in DNA replication activity and an increase in activated dendritic cell infiltration in the tumor microenvironment. Immunohistochemistry analysis demonstrated significant intratumoral increases in neutrophils, T and B lymphocytes, and plasma cells. eCPMV intratumoral immunotherapy demonstrated antitumor efficacy without any adverse effects. This novel immunotherapy has the potential for improving outcomes for human BC patients.
- Published
- 2023
- Full Text
- View/download PDF
88. Cognitive impairment in the HTLV-1 infection: a comparative study associated with functional performance
- Author
-
de Paula, Jonas Jardim, Romanelli, Luiz Claúdio, de Faria, Renata Caetano Vieira, Proietti, Anna Barbara, Malloy-Diniz, Leandro Fernandes, Romano-Silva, Marco Aurélio, de Miranda, Debora Marques, and Nicolato, Rodrigo
- Published
- 2021
- Full Text
- View/download PDF
89. Trends in Cervical Cancer Screening in California's Family Planning Program
- Author
-
Thiel de Bocanegra, Heike, Navarro, Sandy K, Nonzee, Narissa J, Vangala, Sitaram, Zhou, Xinkai, Chang, Charlene, and Moscicki, Anna-Barbara
- Subjects
Reproductive Medicine ,Biomedical and Clinical Sciences ,Cervical Cancer ,Prevention ,Cancer ,Health Services ,Clinical Research ,Good Health and Well Being ,Adult ,California ,Chlamydia Infections ,Family Planning Services ,Female ,Humans ,Mass Screening ,Middle Aged ,Uterine Cervical Neoplasms ,Young Adult ,cervical cytology screening ,chlamydia screening ,Medicaid ,Latinas ,immigrants ,Clinical Sciences ,Obstetrics & Reproductive Medicine ,Clinical sciences - Abstract
ObjectiveGuidelines recommend 3-year cervical cancer screening intervals to avoid unnecessary invasive procedures; however, regular testing remains critical. We evaluated trends in cervical cancer screening among low-income women receiving family planning-related services and their association with patient and provider characteristics.Materials and methodsUsing claims and enrollment data from California's publicly funded family planning program, we identified 540,026 women with a clinician visit at 216 sites between 2011 and 2015. We calculated guideline adherent cervical cancer testing rates for 6-month periods among women aged 21 to 24, 25 to 29, and 30 to 64 years. We also calculated guideline adherent chlamydia testing for women aged 21 to 24 years.ResultsHaving a 3-year cervical cancer screening test declined for all age groups. The odds of cervical cancer screening declined for women aged 21 to 24 years by an estimated 11% every 6 months (odds ratio [OR] = 0.90, 95% confidence interval [CI] = 0.89-0.90), a significantly greater decline than for the other age groups. Among women aged 21 to 29 years, the decrease was significantly larger for Latina (ratio of ORs = 0.95, 95% CI = 0.95-0.96) and Spanish-speaking (ratio of ORs = 0.95, 95% CI = 0.95-0.96) women compared with non-Latina and non-Spanish-speaking women. A smaller decline was seen for chlamydia screening.ConclusionsChanges in screening interval guidelines are associated with overall decreased screening. This trend was strongest among women aged 21 to 24 years, even as they continued to be screened appropriately for chlamydia, suggesting many missed opportunities. Efforts to reduce unnecessary cervical cancer screening should be monitored to maintain appropriate screening rates to avoid advanced-stage diagnoses and higher health care costs.
- Published
- 2018
90. Oral microbiota in youth with perinatally acquired HIV infection.
- Author
-
Starr, Jacqueline R, Huang, Yanmei, Lee, Kyu Ha, Murphy, CM, Moscicki, Anna-Barbara, Shiboski, Caroline H, Ryder, Mark I, Yao, Tzy-Jyun, Faller, Lina L, Van Dyke, Russell B, Paster, Bruce J, and Pediatric HIV/AIDS Cohort Study
- Subjects
Pediatric HIV/AIDS Cohort Study ,Mouth Mucosa ,Saliva ,Humans ,Bacteria ,HIV Infections ,Periodontitis ,Dental Caries ,RNA ,Ribosomal ,16S ,Longitudinal Studies ,Cross-Sectional Studies ,Adolescent ,Adult ,Child ,Female ,Male ,Young Adult ,Microbiota ,Corynebacterium ,Oral microbiome ,Pediatric ,Perinatally infected HIV ,RNA ,Ribosomal ,16S ,Ecology ,Microbiology ,Medical Microbiology - Abstract
BACKGROUND:Microbially mediated oral diseases can signal underlying HIV/AIDS progression in HIV-infected adults. The role of the oral microbiota in HIV-infected youth is not known. The Adolescent Master Protocol of the Pediatric HIV/AIDS Cohort Study is a longitudinal study of perinatally HIV-infected (PHIV) and HIV-exposed, uninfected (PHEU) youth. We compared oral microbiome levels and associations with caries or periodontitis in 154 PHIV and 100 PHEU youth. RESULTS:Species richness and alpha diversity differed little between PHIV and PHEU youth. Group differences in average counts met the significance threshold for six taxa; two Corynebacterium species were lower in PHIV and met thresholds for noteworthiness. Several known periodontitis-associated organisms (Prevotella nigrescens, Tannerella forsythia, Aggregatibacter actinomycetemcomitans, and Filifactor alocis) exhibited expected associations with periodontitis in PHEU youth, associations not observed in PHIV youth. In both groups, odds of caries increased with counts of taxa in four genera, Streptococcus, Scardovia, Bifidobacterium, and Lactobacillus. CONCLUSIONS:The microbiomes of PHIV and PHEU youth were similar, although PHIV youth seemed to have fewer "health"-associated taxa such as Corynebacterium species. These results are consistent with the hypothesis that HIV infection, or its treatment, may contribute to oral dysbiosis.
- Published
- 2018
91. The vaginal microbiota and innate immunity after local excisional treatment for cervical intraepithelial neoplasia
- Author
-
Anita Mitra, David A. MacIntyre, Maria Paraskevaidi, Anna-Barbara Moscicki, Vishakha Mahajan, Ann Smith, Yun S. Lee, Deirdre Lyons, Evangelos Paraskevaidis, Julian R. Marchesi, Phillip R. Bennett, and Maria Kyrgiou
- Subjects
Vaginal microbiota ,Metataxonomics ,Mucosal immunity ,Cervical intraepithelial neoplasia ,Lactobacillus ,Medicine ,Genetics ,QH426-470 - Abstract
Abstract Background Vaginal microbiota (VMB) composition is altered in women with cervical intra-epithelial neoplasia (CIN) compared to healthy controls and is associated with disease progression. However, the impact of CIN excision on the VMB and innate immunity is not known. This observational study aims to explore the impact of CIN excision on the VMB, antimicrobial peptides (AMP) and proinflammatory cytokines. Methods We sampled 103 non-pregnant, premenopausal women at the time of excisional treatment for CIN and at their 6-month follow-up visit. A further 39 untreated controls with normal cytology were also sampled. We used metataxonomics to group vaginal swab samples into community state types (CSTs) and ELISA to quantify cytokine and AMP levels in matched vaginal secretions. Analyses were performed to compare the bacterial composition and immune analyte levels before and after CIN excision and in healthy controls. Results Women with CIN had significantly higher rates of Lactobacillus species depletion pre-treatment compared to healthy controls (CST IV 21/103, 20% vs 1/39, 3%, p = 0.0081). Excision did not change the VMB composition, with CST IV remaining significantly more prevalent after excision compared to untreated, healthy controls (CST IV 19/103, 20% vs 1/39, 3%, p = 0.0142). Prevotella bivia and Sneathia amnii were significantly higher in samples before treatment compared to untreated controls, and Prevotella bivia remained significantly higher amongst the treated, with less Lactobacillus crispatus compared to untreated controls. IL-1β and IL-8 remained significantly elevated pre- (p < 0.0001 and p = 0.0014, respectively) and post-treatment (p < 0.0001 and p = 0.0035, respectively) compared to untreated controls. Levels of human beta-defensin-1 and secretory leukocyte protease inhibitor were both significantly reduced following CIN excision (p < 0.0001); however, their levels remained lower than controls post-treatment. Conclusions Women with CIN have an increased prevalence of Lactobacillus sp. depletion, high-diversity VMB composition, and higher levels of proinflammatory cytokines and AMPs compared to normal controls. Surgical excision of the disease reduces levels of vaginal AMPs but does not alter VMB composition or cytokine levels. These findings suggest that women with CIN have an inherent predisposition to a high-diversity proinflammatory environment that is not corrected by disease excision. The failure to re-establish a Lactobacillus-enriched CST may explain why women remain at high risk of pre-invasive and invasive disease recurrence.
- Published
- 2021
- Full Text
- View/download PDF
92. ASCCP Colposcopy Standards
- Author
-
Khan, Michelle J, Werner, Claudia L, Darragh, Teresa M, Guido, Richard S, Mathews, Cara, Moscicki, Anna-Barbara, Mitchell, Martha M, Schiffman, Mark, Wentzensen, Nicolas, Massad, L Stewart, Mayeaux, EJ, Waxman, Alan G, Conageski, Christine, Einstein, Mark H, and Huh, Warner K
- Subjects
Reproductive Medicine ,Biomedical and Clinical Sciences ,Cancer ,Cervical Cancer ,Patient Safety ,Biopsy ,Colposcopy ,Early Detection of Cancer ,Female ,Humans ,Terminology as Topic ,United States ,Uterine Cervical Neoplasms ,role of colposcopy ,benefits ,potential harms ,terminology ,Clinical Sciences ,Obstetrics & Reproductive Medicine ,Clinical sciences - Abstract
ObjectivesThe American Society for Colposcopy and Cervical Pathology Colposcopy Standards address the role of and approach to colposcopy and biopsy for cervical cancer prevention in the United States. Working Group 1 was tasked with defining the role of colposcopy, describing benefits and potential harms, and developing an official terminology.MethodsA systematic literature review was performed. A national survey of American Society for Colposcopy and Cervical Pathology members provided input on current terminology use. The 2011 International Federation for Cervical Pathology and Colposcopy terminology was used as a template and modified to fit colposcopic practice in the United States. For areas without data, expert consensus guided the recommendation. Draft recommendations were posted online for public comment and presented at an open session of the 2017 International Federation for Cervical Pathology and Colposcopy World Congress for further comment. All comments were considered for the final version.ResultsColposcopy is used in the evaluation of abnormal or inconclusive cervical cancer screening tests. Colposcopy aids the identification of cervical precancers that can be treated, and it allows for conservative management of abnormalities unlikely to progress. The potential harms of colposcopy include pain, psychological distress, and adverse effects of the procedure. A comprehensive colposcopy examination should include documentation of cervix visibility, squamocolumnar junction visibility, presence of acetowhitening, presence of a lesion(s), lesion(s) visibility, size and location of lesions, vascular changes, other features of lesion(s), and colposcopic impression. Minimum criteria for reporting include squamocolumnar junction visibility, presence of acetowhitening, presence of a lesion(s), and colposcopic impression.ConclusionsA recommended terminology for use in US colposcopic practice was developed, with comprehensive and minimal criteria for reporting.
- Published
- 2017
93. Evidence-Based Consensus Recommendations for Colposcopy Practice for Cervical Cancer Prevention in the United States
- Author
-
Wentzensen, Nicolas, Massad, L Stewart, Mayeaux, Edward J, Khan, Michelle J, Waxman, Alan G, Einstein, Mark H, Conageski, Christine, Schiffman, Mark H, Gold, Michael A, Apgar, Barbara S, Chelmow, David, Choma, Kim K, Darragh, Teresa M, Gage, Julia C, Garcia, Francisco AR, Guido, Richard S, Jeronimo, Jose A, Liu, Angela, Mathews, Cara A, Mitchell, Martha M, Moscicki, Anna-Barbara, Novetsky, Akiva P, Papasozomenos, Theognosia, Perkins, Rebecca B, Silver, Michelle I, Smith, Katie M, Stier, Elizabeth A, Tedeschi, Candice A, Werner, Claudia L, and Huh, Warner K
- Subjects
Cervical Cancer ,Cancer ,Prevention ,Colposcopy ,Early Detection of Cancer ,Female ,Humans ,United States ,Uterine Cervical Neoplasms ,colposcopy ,biopsy ,recommendations ,cervical cancer ,screening ,evidence based ,Clinical Sciences ,Obstetrics & Reproductive Medicine - Abstract
The American Society for Colposcopy and Cervical Pathology (ASCCP) Colposcopy Standards recommendations address the role of colposcopy and directed biopsy for cervical cancer prevention in the United States (US). The recommendations were developed by an expert working group appointed by ASCCP's Board of Directors. An extensive literature review was conducted and supplemented by a systematic review and meta-analysis of unpublished data. In addition, a survey of practicing colposcopists was conducted to assess current colposcopy practice in the US. Recommendations were approved by the working group members, and the final revisions were made based on comments received from the public. The recommendations cover terminology, risk-based colposcopy, colposcopy procedures, and colposcopy adjuncts. The ASCCP Colposcopy Standards recommendations are an important step toward raising the standard of colposcopy services delivered to women in the US. Because cervical cancer screening programs are currently undergoing important changes that may affect colposcopy performance, updates to some of the current recommendations may be necessary in the future.
- Published
- 2017
94. ASCCP Colposcopy Standards: Role of Colposcopy, Benefits, Potential Harms, and Terminology for Colposcopic Practice.
- Author
-
Khan, Michelle J, Werner, Claudia L, Darragh, Teresa M, Guido, Richard S, Mathews, Cara, Moscicki, Anna-Barbara, Mitchell, Martha M, Schiffman, Mark, Wentzensen, Nicolas, Massad, L Stewart, Mayeaux, EJ, Waxman, Alan G, Conageski, Christine, Einstein, Mark H, and Huh, Warner K
- Subjects
Humans ,Colposcopy ,Biopsy ,United States ,Uterine Cervical Neoplasms ,Female ,Terminology as Topic ,Early Detection of Cancer ,role of colposcopy ,benefits ,potential harms ,terminology ,Obstetrics & Reproductive Medicine ,Clinical Sciences - Abstract
ObjectivesThe American Society for Colposcopy and Cervical Pathology Colposcopy Standards address the role of and approach to colposcopy and biopsy for cervical cancer prevention in the United States. Working Group 1 was tasked with defining the role of colposcopy, describing benefits and potential harms, and developing an official terminology.MethodsA systematic literature review was performed. A national survey of American Society for Colposcopy and Cervical Pathology members provided input on current terminology use. The 2011 International Federation for Cervical Pathology and Colposcopy terminology was used as a template and modified to fit colposcopic practice in the United States. For areas without data, expert consensus guided the recommendation. Draft recommendations were posted online for public comment and presented at an open session of the 2017 International Federation for Cervical Pathology and Colposcopy World Congress for further comment. All comments were considered for the final version.ResultsColposcopy is used in the evaluation of abnormal or inconclusive cervical cancer screening tests. Colposcopy aids the identification of cervical precancers that can be treated, and it allows for conservative management of abnormalities unlikely to progress. The potential harms of colposcopy include pain, psychological distress, and adverse effects of the procedure. A comprehensive colposcopy examination should include documentation of cervix visibility, squamocolumnar junction visibility, presence of acetowhitening, presence of a lesion(s), lesion(s) visibility, size and location of lesions, vascular changes, other features of lesion(s), and colposcopic impression. Minimum criteria for reporting include squamocolumnar junction visibility, presence of acetowhitening, presence of a lesion(s), and colposcopic impression.ConclusionsA recommended terminology for use in US colposcopic practice was developed, with comprehensive and minimal criteria for reporting.
- Published
- 2017
95. Injectable xyloglucan hydrogels incorporating spheroids of adipose stem cells for bone and cartilage regeneration
- Author
-
Muscolino, Emanuela, Di Stefano, Anna Barbara, Trapani, Marco, Sabatino, Maria Antonietta, Giacomazza, Daniela, Moschella, Francesco, Cordova, Adriana, Toia, Francesca, and Dispenza, Clelia
- Published
- 2021
- Full Text
- View/download PDF
96. Experimental and Theoretical Study of the OH-Initiated Degradation of Piperidine under Simulated Atmospheric Conditions
- Author
-
Tan, Wen, primary, Zhu, Liang, additional, Mikoviny, Tomas, additional, Nielsen, Claus J., additional, Wisthaler, Armin, additional, D’Anna, Barbara, additional, Antonsen, Simen, additional, Stenstrøm, Yngve, additional, Farren, Naomi J., additional, Hamilton, Jacqueline F., additional, Boustead, Graham A., additional, Ingham, Trevor, additional, and Heard, Dwayne E., additional
- Published
- 2024
- Full Text
- View/download PDF
97. Secondary organic aerosol formed by Euro 5 gasoline vehicle emissions: chemical composition and gas-to-particle phase partitioning
- Author
-
Kostenidou, Evangelia, primary, Marques, Baptiste, additional, Temime-Roussel, Brice, additional, Liu, Yao, additional, Vansevenant, Boris, additional, Sartelet, Karine, additional, and D'Anna, Barbara, additional
- Published
- 2024
- Full Text
- View/download PDF
98. Tumor-infiltrating γδ T cells as targets of immune checkpoint blockade in melanoma
- Author
-
Di Simone, Marta, primary, Corsale, Anna Maria, additional, Toia, Francesca, additional, Shekarkar Azgomi, Mojtaba, additional, Di Stefano, Anna Barbara, additional, Lo Presti, Elena, additional, Cordova, Adriana, additional, Montesano, Luigi, additional, Dieli, Francesco, additional, and Meraviglia, Serena, additional
- Published
- 2024
- Full Text
- View/download PDF
99. Assessment of compression forces in a digitally modified short leg cast for pressure injury risk monitoring in healthy children
- Author
-
Vrankovic, Matia Iva, primary, Annaheim, Simon, additional, Willibald, Jana, additional, Lieber, Jan, additional, van Hedel, Hubertus J. A., additional, Schlüer, Anna-Barbara, additional, Rossi, René M., additional, and Meyer-Heim, Andreas, additional
- Published
- 2024
- Full Text
- View/download PDF
100. Impact of Management Guidelines for Abnormal Cervical Cytology on Colposcopy Procedure Rates Among Young Women
- Author
-
Nonzee, Narissa J., primary, Thiel de Bocanegra, Heike, additional, Navarro, Sandy, additional, Bastani, Roshan, additional, Glenn, Beth, additional, Kominski, Gerald F., additional, and Moscicki, Anna-Barbara, additional
- Published
- 2024
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.